Showing results (181-190 of 1,186) with videos related to
Sort By:
Pageof 119
Pharmaceutical Statistics|September 27, 2022
An adaptive biomarker basket design in phase II oncology trialsShufang Liu, Kentaro Takeda, Alan RongPharmaceutical Statistics|January 21, 2021
A novel equivalence probability weighted power prior for using historical control data in an adaptive clinical trial design: A comparison to standard methodsMaxine Bennett, Simon White, Nicky Best, et al.Pharmaceutical Statistics|January 21, 2021
Assessing efficacy in important subgroups in confirmatory trials: An example using Bayesian dynamic borrowingNicky Best, Robert G Price, Isabelle J Pouliquen, et al.Pharmaceutical Statistics|March 6, 2021
A comparison of reweighting estimators of average treatment effects in real world populationsChen-Yen Lin, Eloise Kaizar, Douglas Faries, et al.Pharmaceutical Statistics|March 6, 2021
Matrix decomposition in meta-analysis for extraction of adverse event pattern and patient-level safety profileKentaro Matsuura, Jun Tsuchida, Shuji Ando, et al.Pharmaceutical Statistics|December 15, 2021
Improving the assessment of the probability of success in late stage drug developmentLisa V Hampson, Björn Bornkamp, Björn Holzhauer, et al.Pharmaceutical Statistics|October 24, 2022
Statistical considerations for design and analysis of stability, comparability and formulation testsDaniel Coleman, Tony PourmohamadPharmaceutical Statistics|February 22, 2022
Sample size re-estimation for response-adaptive randomized clinical trialsXin Li, Feifang HuPharmaceutical Statistics|February 22, 2022
Estimation and expected sample size in Simon's two-stage designs that stop as early as possibleAntonios Daletzakis, Rutger van den Bor, Marianne A Jonker, et al.Pharmaceutical Statistics|May 1, 2019
A flexible parametric survival model for fitting time to event data in clinical trialsJason J Z Liao, Guanghan Frank LiuPageof 119